ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $298,856 | -6.4% | 3,554 | +0.3% | 0.00% | -20.0% |
| Q3 2021 | $319,453 | -8.5% | 3,542 | -3.3% | 0.01% | 0.0% |
| Q2 2021 | $349,076 | -82.0% | 3,661 | -78.5% | 0.01% | -82.8% |
| Q1 2021 | $1,934,481 | -20.5% | 16,990 | -3.4% | 0.03% | -19.4% |
| Q4 2020 | $2,433,599 | +79.2% | 17,580 | +6.4% | 0.04% | +50.0% |
| Q3 2020 | $1,357,861 | +0.7% | 16,521 | -4.1% | 0.02% | 0.0% |
| Q2 2020 | $1,348,043 | +82.9% | 17,234 | +3.9% | 0.02% | +50.0% |
| Q1 2020 | $737,005 | -0.2% | 16,588 | -4.1% | 0.02% | +33.3% |
| Q4 2019 | $738,840 | -2.4% | 17,299 | -2.3% | 0.01% | -7.7% |
| Q3 2019 | $757,120 | -29.4% | 17,698 | +4.8% | 0.01% | -27.8% |
| Q2 2019 | $1,072,578 | -7.1% | 16,891 | +1.4% | 0.02% | -14.3% |
| Q1 2019 | $1,155,052 | +72.7% | 16,653 | +8.2% | 0.02% | +61.5% |
| Q4 2018 | $668,940 | -42.3% | 15,385 | +1.3% | 0.01% | -38.1% |
| Q3 2018 | $1,159,376 | -99.9% | 15,187 | 0.0% | 0.02% | +10.5% |
| Q2 2018 | $1,167,425,000 | +61.8% | 15,187 | +7.3% | 0.02% | +90.0% |
| Q1 2018 | $721,509,000 | +122605.6% | 14,150 | +11.7% | 0.01% | +25.0% |
| Q4 2017 | $588,000 | -58.3% | 12,669 | -52.1% | 0.01% | -11.1% |
| Q3 2017 | $1,410,000 | -14.2% | 26,473 | 0.0% | 0.01% | -18.2% |
| Q2 2017 | $1,644,000 | -8.4% | 26,473 | 0.0% | 0.01% | -8.3% |
| Q1 2017 | $1,794,000 | +1.4% | 26,473 | +5.2% | 0.01% | -7.7% |
| Q4 2016 | $1,770,000 | -2.5% | 25,174 | -1.7% | 0.01% | 0.0% |
| Q3 2016 | $1,816,000 | +33.8% | 25,599 | -7.7% | 0.01% | +30.0% |
| Q2 2016 | $1,357,000 | -22.8% | 27,747 | 0.0% | 0.01% | -28.6% |
| Q1 2016 | $1,757,000 | -40.9% | 27,747 | +4.7% | 0.01% | -39.1% |
| Q4 2015 | $2,973,000 | +16.5% | 26,504 | 0.0% | 0.02% | +27.8% |
| Q3 2015 | $2,553,000 | -0.2% | 26,504 | +6.1% | 0.02% | 0.0% |
| Q2 2015 | $2,557,000 | +914.7% | 24,976 | +334.5% | 0.02% | +800.0% |
| Q4 2014 | $252,000 | -22.5% | 5,748 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $325,000 | -0.3% | 5,748 | -20.8% | 0.00% | 0.0% |
| Q2 2014 | $326,000 | -10.9% | 7,259 | -3.0% | 0.00% | -33.3% |
| Q1 2014 | $366,000 | – | 7,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |